Science 37

Science 37

Uses advanced telemedicine technology and patient-centric innovative networked clinical research models to rapidly accelerate biomedical discovery and bring down the costs of clinical trials.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD202020212022202320242025
Revenues23.7m59.6m70.1m58.4m62.8m75.2m
% growth-151 %18 %(17 %)8 %20 %
EBITDA(26.5m)(24.6m)(139m)(32.4m)(17.1m)(2.9m)
% EBITDA margin(112 %)(41 %)(199 %)(55 %)(27 %)(4 %)
Profit(31.7m)(94.3m)(51.0m)(72.8m)(38.4m)(24.9m)
% profit margin(134 %)(158 %)(73 %)(125 %)(61 %)(33 %)
EV / revenue-20.4x-0.8x-0.3x0.3x0.6x
EV / EBITDA--49.4x0.4x0.5x-1.1x-15.8x
  • Edit
DateInvestorsAmountRound
-

N/A

-

$6.5m

Series A

$31.0m

Series B

$29.0m

Series C

$31.0m

Series B

$35.0m

Series D

$40.0m

Late VC

$75.0m

Valuation: $1.1b

44.3x EV/LTM Revenues

-39.7x EV/LTM EBITDA

SPAC IPO

$200m

Valuation: $1.1b

44.3x EV/LTM Revenues

-39.7x EV/LTM EBITDA

SPAC Private Placement
*

$38.0m

Valuation: $38.0m

Acquisition
Total Funding€339m

Recent News about Science 37

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Science 37

Edit
Vault Health life sciences platform
ACQUISITION by Science 37 Feb 2023